Menu Close

Articles on Pfizer

Displaying 1 - 20 of 35 articles

Getting vaccines to rural and hard-to-reach areas is critical for public health and ethical reasons. Hector Roqueta Rivero/Moment via Getty Images

The cold supply chain can’t reach everywhere – that’s a big problem for equitable COVID-19 vaccination

So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can't support a cold supply chain.
Efficient shipping and storage could prevent a lot of wasted vaccines. AP Photo/Morry Gash, Pool

What vaccine distribution planners can learn from Amazon and Walmart

COVID-19 vaccines have very specific storage requirements that make shipping a difficult task. Two ideas – fulfillment centers and cross-docking – could help overcome some distribution challenges.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Tony Potts, a 69-year-old retiree, removes his face mask for a temperature check just before receiving his first injection in a phase 3 COVID-19 vaccine clinical trial sponsored by Moderna. Potts is one of 30,000 participants in the Moderna trial. Paul Hennessy/NurPhoto via Getty ImageS

What are emergency use authorizations, and do they guarantee that a vaccine or drug is safe?

The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
A volunteer gets an injection of Moderna’s possible COVID-19 vaccine on July 27, 2020. Moderna announced Nov. 16 that its vaccine is proving highly effective in a major trial. (AP Photo/Hans Pennink)

COVID-19 vaccines: How Pfizer’s and Moderna’s 95% effective mRNA shots work

Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
Pfizer stock surged higher on Nov. 9 after the company announced its vaccine is “90% effective” against COVID-19 infections. KENA BETANCUR/AFP via Getty Images

Why we didn’t get a vaccine by Election Day – but why we may get one soon

With COVID-19 cases soaring across the US and worldwide, the need for a vaccine could not be greater. Here's where we stand on vaccine development, including positive results from Pfizer's trial.

Top contributors

More